Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Clinical Studies
  • View item
  • Home
  • ICR Divisions
  • Clinical Studies
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma - A Single Centre Retrospective Analysis.

Thumbnail
View/Open
Published version (459.1Kb)
ICR Author
Judson, Ian
Author
Walls, GM
Zaidi, SH
Fotiadis, N
Jordan, S
Maruzzo, M
Hamid, I
Al-Muderis, O
Khabra, K
Benson, C
Jones, RL
Judson, IR
Miah, AB
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
<h4>Background/aim</h4>Distinguishing true oligometastatic disease from early polymetastatic disease is vital in patients with soft tissue sarcoma as contemporary treatment strategies differ significantly. Clinical factors such as tumour biology, organ involved, number of lesions, and patient fitness influence clinical decisions.<h4>Patients and methods</h4>A retrospective search of a prospective database identified patients with new distant relapse, treated between 2009 and 2012.<h4>Results</h4>A total of 223 patients were included, and oligometastases were diagnosed in 81 (36%) patients, which were pulmonary in just over half of cases. These were treated with local therapy in 66 of 89 cases, and 7 patients received subsequent treatment for additional oligometastases. Metastasectomy was the most common treatment modality. A total of 16/66 patients (24%) underwent active surveillance for >6 months prior to local therapy.<h4>Conclusion</h4>Patients with oligometastatic disease can experience durable disease control with timely multimodality treatment approaches for evolving metastatic disease, where disease biology allows.
URI
https://repository.icr.ac.uk/handle/internal/4933
DOI
https://doi.org/10.21873/anticanres.15325
Collections
  • Clinical Studies
Subject
Humans
Sarcoma
Antineoplastic Combined Chemotherapy Protocols
Prognosis
Combined Modality Therapy
Survival Rate
Retrospective Studies
Prospective Studies
Adolescent
Adult
Aged
Aged, 80 and over
Middle Aged
Female
Male
Young Adult
Metastasectomy
Research team
Sarcoma Clinical Trials
Language
eng
Date accepted
2021-09-06
Citation
Anticancer research, 2021, 41 (10), pp. 5089 - 5096

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.